Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KSR-001 in Healthy Male Volunteers for Dry Eye Syndrome
NCT05017870Phase 1Completed
- Sponsor
- Kukje Pharm
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rebamipide in dry eye syndrome (DED), sponsored by Kukje Pharm. Started Dec 2018; status: completed.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05017870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017870.